Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 12Unknown 5Terminated 4Active not recruiting 4Recruiting 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 24Pancreatic Neoplasms 14Stomach Neoplasms 12Rectal Neoplasms 12Squamous Cell Carcinoma of Head and Neck 9Esophageal Neoplasms 9Colonic Neoplasms 9Neoplasms 7Adenocarcinoma Of Esophagus 7Urinary Bladder Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasm Metastasis 4Head and Neck Neoplasms 4Esophageal Squamous Cell Carcinoma 4Cholangiocarcinoma 4Breast Neoplasms 4Anus Neoplasms 4Ovarian Neoplasms 3Nasopharyngeal Carcinoma 2Melanoma 2Hepatoblastoma 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Clinical Stage I Gastric Cancer AJCC v8 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Urethral Neoplasms 1Urachal cancer 1Unresectable Colorectal Cancer 1

Interventions

Mitomycin 5Specimen Handling 4Nivolumab 4Magnetic Resonance Spectroscopy 4Fluorouracil 4Capecitabine 4Biopsy 4pembrolizumab 3Drug Therapy 3dehydroftorafur 2Vaccines 2Sigmoidoscopy 2Radiotherapy, Intensity-Modulated 2Radiation 2Proctoscopy 2Mitozytrex 2Fluorodeoxyglucose F18 2Colonoscopy 2tislelizumab 1spartalizumab 1entinostat 1durvalumab 1bintrafusp alfa protein, human 1X-Rays 1Watchful Waiting 1Vaccines, Synthetic 1Tomography, X-Ray Computed 1Taxes 1Surveys and Questionnaires 1Sentinel Lymph Node Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Anus Neoplasms × Fluorouracil × Clear all
NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

NCT04166318 2026-05-05

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
252 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT03018418 2024-09-19

Proton Therapy in Reducing Toxicity in Anal Cancer

University of Cincinnati

Phase 2 Active not recruiting
14 enrolled 14 charts
Gastrointestinal

Anus Neoplasms

NCT04230759 2024-09-19

RADIANCE

Goethe University

Phase 2 Active not recruiting
180 enrolled
Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡